{"database": "lobbying", "table": "lobbying_activities", "rows": [[1582051, "d63966d0-673e-4d77-ab6c-7da99e75d932", "Q3", "RED+BLUE STRATEGIES", 400693064, "EXPRESS SCRIPTS INC.", 2014, "third_quarter", "MMM", "Monitoring ongoing Medicare and Medicaid regulations and guidance related to prescription medications, PBMs, and related entities. \n\nMonitoring potential health-related offsets related to Medicare Part D and the Medicaid drug benefit. \n\nExchange-based pharmacy benefit structure and coverage issues. \n\nIssues related to regulations and guidance that impact mail order and specialty pharmacies for Medicare purposes. \n\nPolices related to prescription drug diversion and abuse. \n\nIssues related to Part D coverage for Medicare Beneficiaries in Hospice Care.\n\nIssues related to coding and reimbursement of biosimilars.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2014-10-06T16:04:11.580000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1582051"], "units": {}, "query_ms": 0.9574029827490449, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}